inHEART Models

by inHEART  · Based in France → — The world's most advanced, AI-enabled, DIGITAL TWIN OF THE HEART for image guided ablations.
Cardiology Radiology
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

inHEART Models is an AI-driven software solution that creates highly detailed, interactive 3D digital twin models of a patient’s heart from pre-procedural CT and/or MR images. This technology is designed to optimize treatment strategies and enhance image-guided cardiac ablation procedures, particularly for complex arrhythmias like ventricular tachycardia (VT). The proprietary segmentation algorithm analyzes medical images to provide unprecedented anatomical insights into tissue and structural characteristics, allowing physicians to plan procedures with greater precision and efficiency. The solution integrates seamlessly into major electroanatomic mapping (EAM) systems, supporting both pre-procedural planning and intraprocedural use. Early clinical evaluations have shown its potential to significantly reduce VT procedure times and recurrence rates.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-driven digital twin of the heart
  • Automated segmentation of CT and MR images
  • Highly detailed, interactive 3D cardiac models
  • Pre-procedural planning and optimization of treatment strategies
  • Seamless integration with major electroanatomic mapping (EAM) systems (Cartou00ae, Rhythmiau2122, Ensiteu2122, Afferau2122)
  • Potential to reduce VT procedure times by 60%
  • Potential to reduce VT recurrence rates by 38%
  • Cloud-based platform for interactive exploration
  • 24-hour turnaround for 3D model generation
  • Unprecedented anatomical details of tissue and structural characteristics

Use Cases

  • Image-guided cardiac ablation procedures
  • Pre-procedural planning for ventricular tachycardia (VT) ablations
  • Optimizing treatment strategies for complex cardiac arrhythmias
  • Enhanced visualization of cardiac anatomy for physicians
  • Risk stratification for Sudden Cardiac Death (in consortiums)
  • Screening for Cardioembolic Stroke risk (in consortiums)

What Physicians Need to Know

Cardiac CT/MRI Analysis
inHEART Models utilizes proprietary AI-driven segmentation algorithms to analyze pre-procedural CT and/or MR images, generating highly detailed, interactive 3D models of the heart. This includes segmentation of cardiac chambers, endocardium, great vessels, coronary arteries, epicardial fat, and the phrenic nerve, along with assessment of myocardial architecture, scar, and fibrosis based on delayed contrast retention.
Arrhythmia Management Support
The tool is designed to optimize treatment strategies for complex cardiac ablation procedures, particularly for ventricular tachycardia (VT), by providing precise 3D models that delineate arrhythmogenic areas within scar tissue. Early clinical evaluations suggest a potential to reduce VT procedure times by 60% and improve success rates by 15% (from 60% to 75%), and reduce VT recurrence rates by 38%. Its AI can simulate electrical activity to pinpoint the origins of ventricular fibrillation.
Coronary Artery Assessment
As part of its comprehensive 3D cardiac modeling from CT images, inHEART Models is capable of segmenting coronary arteries, providing crucial anatomical detail for pre-procedural planning.
Cardiac Monitoring Integration
The inHEART system seamlessly integrates into all major electroanatomic mapping (EAM) systems, facilitating advanced intraprocedural guidance during cardiac ablation procedures.
Risk Stratification (via Partnerships)
Through strategic partnerships, inHEART's AI-based digital twin technology is leveraged for risk stratification. This includes identifying patients at risk of Sudden Cardiac Death using cardiac CT and ECG, and screening for Cardioembolic Stroke risk via chest CT and ECG.
Physician Tip

inHEART Models offers a powerful solution for personalized pre-procedural planning and intraprocedural guidance in complex cardiac ablation cases, particularly for ventricular tachycardia. Leverage the highly detailed 3D anatomical and scar characterization to optimize ablation strategies, potentially reducing procedure times and improving patient outcomes. The ability to visualize scar transmurality and other tissue characteristics can significantly enhance targeting accuracy. Utilize the seamless integration with EAM systems for a more guided and efficient intervention.

inHEART Models is designed for seamless integration with all major electroanatomic mapping (EAM) systems, allowing for the direct export and display of its 3D digital heart models for real-time intraprocedural guidance during ablation procedures. The solution is provided as a cloud-based service, where clinical sites upload CT/MR images and receive back the 3D digital twin.

Details

Category Cardiology AI, Radiology & Imaging AI, Surgical AI
Pricing Contact for pricing — Not publicly disclosed; contact vendor for details.
DeploymentCloud-based
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

inHEART Models received initial FDA 510(k) clearance in May 2022 for its software suite enabling 3D visualization and analysis of anatomical structures for pre-procedural planning and intraprocedural use. An advanced AI software module (K231683) received 510(k) clearance in March 2024, enabling first-of-its-kind, fully automated segmentation of CT images for creating 3D cardiac models.
Integrations
EHR Not specified
Specialties Cardiology, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate inHEART Models

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

inHEART
inHEART Receives FDA Clearance For Advanced AI-Driven Software Module That Optimizes the Creation of 3D Models of the Heart
inHEART announced FDA clearance for its AI-driven software module, which automates the creation of 3D heart models, enhancing speed and efficiency for cardiac ablation procedures.
2024-01
inHEART
inHEART Raises $11M To Accelerate Development & Deployment of Novel Therapeutic, Predictive, and Screening Cardiac Solutions
inHEART secured $11 million in funding to expand the commercial reach of its digital twin of the heart in various global markets and to develop new software solutions across the cardiac care continuum.
2024-03
Medical Device Network
FDA issues 510(k) clearance for inHEART's AI cardiac software
The FDA granted 510(k) clearance for inHEART's AI software module, designed to optimize the creation of 3D heart models by automating CT image segmentation for cardiac ablations.
2024-03
inHEART
inHEART receives CE certification under new MDR for novel, AI-based, digital twin of the heart
inHEART received CE certification under the new European Medical Device Regulation (MDR 2017/745) for its inHEART MODELS software suite, enabling 3D visualization and analysis for image-guided cardiac ablations.
2023-05
Expert Review of Medical Devices (Taylor & Francis Online)
inHEART Models software u2013 novel 3D cardiac modeling solution
This review article highlights the market overview and application of inHEART Models and MUSIC software in ventricular tachycardia (VT) ablations, discussing its clinical profile and regulatory status.
2023-08
inHEART
inHEART Receives FDA Clearance for Novel 3D Cardiac Modeling Solution
inHEART announced FDA 510(k) clearance for its inHEART MODELS software suite, which provides 3D visualization and analysis of anatomical structures for pre-procedural planning and intraprocedural use in cardiac ablations.
2022-05
Xtalks
3D Heart Modeling Solution By inHEART Gets FDA Clearance
inHEART's new 3D heart modeling solution received FDA 510(k) clearance, allowing for 3D visualization and analysis of the heart for pre-procedural planning and intraprocedural use in cardiac ablation procedures.
2022-06
Cardiac Rhythm News
FDA approval granted for inHEART 3D imaging analysis software
inHEART received FDA 510(k) clearance for its inHEART Models software suite, enabling 3D visualization and analysis of cardiac structures for pre-procedural planning and intraprocedural use, aiming to improve cardiac ablation efficiency.
2022-05

Videos

Product demos, reviews, and walkthroughs for inHEART Models.

View all on YouTube

Frequently Asked Questions

inHEART Models creates highly detailed, interactive 3D cardiac models from pre-procedural CT and/or MR images, which are used to optimize treatment strategies based on each patient's unique anatomy. It seamlessly integrates into all major electroanatomic mapping (EAM) systems, supporting both pre-procedural planning and intraprocedural guidance.
Yes, inHEART Models received FDA 510(k) clearance for its software suite in May 2022 and an advanced AI software module in March 2024. While specific HIPAA compliance details are not publicly detailed, as a cloud-based medical device handling protected health information, it is expected to adhere to HIPAA regulations, which may involve hospital-specific risk assessments.
The AI software module is currently indicated for adults only and primarily utilizes CT images, with limited support for other imaging modalities like intracardiac echo files. It is contraindicated for primary diagnostic interpretation of mammography images, and the physician remains solely responsible for all final patient management decisions.
inHEART Models aims to significantly improve upon conventional ablation procedures by providing detailed 3D models that have shown potential to reduce ventricular tachycardia (VT) procedure times by 60% and recurrence rates by 38%. Other competing technologies in the market include Automatic Detection of Arrhythmia Substrate (ADAS) 3D software and Catheter Precision's View into Ventricular Onset (VIVO).
The specific pricing structure for inHEART Models, including subscription tiers, is not publicly listed and typically requires direct engagement with the company for a quote. The solution is provided as a cloud-based service, where clinical sites upload patient images and receive the processed 3D digital twin, suggesting a subscription or per-case payment model.
inHEART Models is primarily designed to optimize pre-procedural planning and guidance for cardiac ablation procedures, especially for ventricular tachycardia (VT). It helps physicians gain unparalleled anatomical insights and precisely identify arrhythmogenic areas within scar tissue.
Early clinical evaluations have demonstrated a potential to reduce VT procedure times by 60% and decrease recurrence rates by 38% compared to conventional ablation strategies. Furthermore, inHEART is actively conducting randomized controlled trials, such as the inEurHeart study, to further validate its impact on clinical practice and patient outcomes.

Compare inHEART Models

VS
inHEART Models vs PMcardio
Cardiology AI Adjacent · 65/100
inHEART Models focuses on creating detailed 3D digital twin models of the heart from CT/MR images for optimizing cardiac ablation procedures. PMcardio, on the other hand, specializes in…
VS
inHEART Models vs EchoNext
Cardiology AI Adjacent · 65/100
These tools are adjacent in their focus on cardiology AI, but serve different stages of patient care. inHEART Models is designed for pre-procedural planning and optimization of cardiac…
VS
inHEART Models vs KardiaPro
Cardiology AI Adjacent · 60/100
While both tools operate within cardiology and leverage AI with FDA clearance, their core functionalities differ significantly. inHEART Models focuses on pre-procedural planning for cardiac ablations using 3D…
VS
SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs inHEART Models
Cardiology AI Adjacent · 60/100
These two tools are adjacent in the cardiology AI space, but serve distinct purposes. SENSICARDIAC MOBI focuses on the diagnostic phase, aiding physicians in identifying heart murmurs through…

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.